14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
ZGM vs HURN: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Huron Consulting Group Inc. (HURN) is the stronger overall head-to-head candidate over Zenta Group Company Limited (ZGM) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). ZGM carries a Unified Composite Score of 59.4/100 (HOLD) at $1.65 (N/M Forward P/E, 31.7% operating margin), whereas HURN carries 77.7/100 (STRONG BUY) at $172.21 (16.3x Forward P/E, 12.4% operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ZGM vs HURN. Trailing 12-month operating profitability (ZGM 31.7% vs HURN 12.4%) and valuation multiples (ZGM N/M vs HURN 16.3x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Consulting Services value chain with $2.6B market capitalization and 12.4% operating margin.
OpEx & R&D Reinvestment20.2% of Rev ($368M)
90D Engineering Disclosures0 Published
Investor FAQ ZGM vs HURN Key Questions & Quantitative Answers
As of Nov 20, 2026, Huron Consulting Group Inc. (HURN) is the stronger overall head-to-head candidate over Zenta Group Company Limited (ZGM) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). ZGM carries a Unified Composite Score of 59.4/100 (HOLD) at $1.65 (N/M Forward P/E, 31.7% operating margin), whereas HURN carries 77.7/100 (STRONG BUY) at $172.21 (16.3x Forward P/E, 12.4% operating margin). Technically, ZGM sits in a Neutral phase (RSI 51.6, UNCLASSIFIED options structure) and HURN sits in a Neutral phase (RSI 48.5, CONSOLIDATION options structure).
HURN leads the Growth & Scale pillar: ZGM posts -27.0% YoY revenue growth and -78.0% YoY earnings growth on $3.2M TTM revenue (78.1% gross margin, 31.7% operating margin), compared with HURN at +11.6% YoY revenue growth and +2.3% YoY earnings growth on $1.82B TTM revenue (32.6% gross margin, 12.4% operating margin). On trailing 12-month operating scale, ZGM generates $3.2M in USD-normalized revenue versus $1.82B for HURN. In operating R&D and SG&A reinvestment, ZGM deploys 46.4% of Rev ($1.5M) (0 90-day corporate R&D disclosures) versus 20.2% of Rev ($368M) (0 disclosures) for HURN.
HURN screens cheaper on headline valuation multiples. ZGM trades at N/M Forward P/E, 15.4x Trailing P/E, N/M PEG, and 5.7x EV/Revenue (42.7% EBITDA margin), whereas HURN trades at 16.3x Forward P/E, 25.0x Trailing P/E, 1.52x PEG, and 1.9x EV/Revenue (14.0% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ZGM (23.4% ROE) versus HURN (25.4% ROE) capital efficiency.
In options market volatility and institutional positioning, ZGM carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.88β · 161% Vol realized risk). By comparison, HURN carries 46.7% implied volatility (10th %ile, Compressed (<25th %ile)), a 569.33x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (-1.17β · 54% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.